Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Trinity Biotech PLC (NASDAQ:TRIB)

13.09
Delayed Data
As of 3:59pm ET
 +0.06 / +0.46%
Today’s Change
9.20
Today|||52-Week Range
13.68
+11.31%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$312.2M

Company Description

Trinity Biotech Plc develops, manufactures and markets diagnostic test kits for the clinical laboratory. Its products are used to detect autoimmune, infectious and sexually transmitted diseases, autoimmune disorders, cardiac arrest, haemoglobin disorders, diabetes and disorders of the liver and intestine.The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.

Contact Information

Trinity Biotech Plc
IDA Business Park
Bray Wicklow --
P:(531) 276-9800
Investor Relations:

Employees

Shareholders

Other institutional45.44%
Mutual fund holders26.33%
Individual stakeholders--

Top Executives

Ronan O'CaoimhChairman & Chief Executive Officer
Kevin TansleyCFO, Secretary & Head-Investor Relations
James WalshExecutive Director & Chief Scientific Officer